http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#Head
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#assertion
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#provenance
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#pubinfo
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#assertion
http://purl.obolibrary.org/obo/DOID_3890
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_3890
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB03404
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association
http://www.w3.org/2000/01/rdf-schema#label
panhematin is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women after initial carbohydrate therapy is known or suspected to be inadequate limitations of use see dosage and administration 2 1 panhematin is a hemin for injection indicated for amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women after initial carbohydrate therapy is known or suspected to be inadequate 1 limitations of use 1 1
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB03404
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#provenance
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#pubinfo
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#sig
http://purl.org/nanopub/x/hasSignature
hxfxyh/sIrYQJPe9p9pFo7WHjfTDqZ+dWlxILBHEzCcOZv/Ipf4ha0SHnT98fZ5wfTav1jKKlbXvmy6wWCZ1V1lliiXC9HLdcKzDwYeI5ewI6JY3yQ0JDH3+YJ+S74H3laYfabI03bcxqbZMWXwR8dmMRW8D1vtoq+Qx4hlVWFw=
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
http://purl.org/dc/terms/created
2021-07-03T15:46:34.917+02:00
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs